Period20 Feb 2020

Media coverage

1

Media coverage

  • TitleClinical Trial: Rigosertib Plus Nivolumab for KRAS+ NSCLC Patients Who Progressed on First-Line Treatment
    Media name/outletHealth Daily Digest (Ht Media)
    Country/TerritoryIndia
    Date20/02/20
    PersonsRajwanth Veluswamy